Document Detail


Peripheral embolism due to bone entrapment of the popliteal artery after valgus osteotomy: a case report.
MedLine Citation:
PMID:  17494852     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The authors report on a case of arterial embolism caused by bone entrapment of the popliteal artery due to a protrusion of a hydroxyl-apatite wedge. The wedge had been placed 4 years earlier during the course of a valgus osteotomy procedure. Thrombolytic therapy was performed, and the wedge was removed. Because causes for arterial embolism vary, the knowledge of its underlying mechanism is necessary to avoid recurring events. Bone entrapment after knee surgery is a differential diagnosis that should be taken into account, even years after surgery.
Authors:
Kilian Rittig; Michael Fenchel; Nora Greipel; Hans-Ulrich Häring; Bernd Balletshofer
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Journal of vascular and interventional radiology : JVIR     Volume:  18     ISSN:  1051-0443     ISO Abbreviation:  J Vasc Interv Radiol     Publication Date:  2007 May 
Date Detail:
Created Date:  2007-05-14     Completed Date:  2007-06-28     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  9203369     Medline TA:  J Vasc Interv Radiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  677-80     Citation Subset:  IM    
Affiliation:
Department of Endocrinology, Eberhard-Karls-University of Tuebingen, Otfried-Müller Strasse 10, 72076 Tübingen, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Angiography
Arterial Occlusive Diseases / etiology*,  radiography,  therapy
Biocompatible Materials / adverse effects
Durapatite / adverse effects
Embolism
Female
Fibrinolytic Agents / administration & dosage
Humans
Infusions, Intra-Arterial
Middle Aged
Osteotomy / adverse effects*
Popliteal Artery*
Thrombolytic Therapy
Urokinase-Type Plasminogen Activator / administration & dosage
Chemical
Reg. No./Substance:
0/Biocompatible Materials; 0/Fibrinolytic Agents; 1306-06-5/Durapatite; EC 3.4.21.73/Urokinase-Type Plasminogen Activator

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Dual use of an amplatzer device in the transcatheter embolization of a large high-flow renal arterio...
Next Document:  Features influencing patient selection for fibroid treatment with magnetic resonance-guided focused ...